Teleflex (NYSE:TFX) Posts Earnings Results, Beats Estimates By $0.29 EPS

Teleflex (NYSE:TFX) released its quarterly earnings results on Thursday. The medical technology company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.29, Zacks reports. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The company had revenue of $892.90 million for the quarter, compared to analyst estimates of $892.79 million. During the same period in the previous year, the company posted $3.49 earnings per share. The firm’s revenue was up 19.4% on a year-over-year basis. Teleflex updated its FY 2025 guidance to 14.000-14.200 EPS.

Teleflex Trading Up 0.9%

NYSE:TFX traded up $0.93 on Friday, reaching $109.44. The company’s stock had a trading volume of 217,567 shares, compared to its average volume of 740,414. The firm has a market cap of $4.84 billion, a PE ratio of 25.78, a PEG ratio of 1.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The business’s 50-day moving average price is $126.01 and its two-hundred day moving average price is $123.27. Teleflex has a 1-year low of $102.58 and a 1-year high of $200.15.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is presently 32.00%.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Osaic Holdings Inc. boosted its position in Teleflex by 17.5% during the 2nd quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock worth $148,000 after acquiring an additional 186 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of Teleflex by 15.8% in the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares during the last quarter. California Public Employees Retirement System raised its position in shares of Teleflex by 0.5% in the second quarter. California Public Employees Retirement System now owns 78,711 shares of the medical technology company’s stock valued at $9,316,000 after purchasing an additional 391 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Teleflex by 108.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after buying an additional 521 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in Teleflex by 211.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,110 shares of the medical technology company’s stock valued at $131,000 after acquiring an additional 754 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on TFX shares. Mizuho boosted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research report on Friday, August 1st. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $120.00 price objective on shares of Teleflex in a research note on Friday. Wall Street Zen downgraded shares of Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. Weiss Ratings restated a “sell (d+)” rating on shares of Teleflex in a report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their price target on shares of Teleflex from $137.00 to $131.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $139.43.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.